Osteoarthritis Drug Market Size, Share, And Growth Report 2032
Osteoarthritis Drug Market by Drug Class (NSAIDs, Corticosteroids, Viscosupplementation Agents, and Others), by Route of Administration (Topical, Parenteral, and Oral), by Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), and By Region - Global And Regional Industry Overview, market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024-2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 9.35 Billion | USD 16.91 Billion | 6.8% | 2023 |
Table Of Content
- Chapter 1. Introduction
- 1.1. Report description and scope
- 1.2. Research scope
- 1.3. Research methodology
- 1.3.1. Market research process
- 1.3.2. Market research methodology
- Chapter 2. Executive Summary
- 2.1. Global Osteoarthritis Drug Market, 2016 - 2025 (USD Million)
- 2.2. Global Osteoarthritis Drug Market: Snapshot
- Chapter 3. Osteoarthritis Drug Market - Industry Dynamics
- 3.1. Introduction
- 3.2. Market drivers
- 3.2.1. Global Osteoarthritis Drug Market drivers: Impact analysis
- 3.2.2. Increased prevalence of Osteoarthritis
- 3.2.3. increase in healthcare facilities, expenditure on advanced and developing healthcare facilities
- 3.3. Market Restraints
- 3.3.1. Side-effects of Osteoarthritis Drug
- 3.3.2. Low adoption rate
- 3.4. Opportunities
- 3.4.1. High spending on R&D
- 3.4.2. Adoption of innovative products
- 3.4.3. FDA Approval
- 3.5. Porter's Five Forces analysis
- 3.5.1. Bargaining power of suppliers
- 3.5.2. Bargaining power of buyers
- 3.5.3. The threat from new entrants
- 3.5.4. The threat from new substitutes
- 3.5.5. Degree of competition
- 3.6. Market attractiveness analysis
- 3.6.1. Market attractiveness analysis, by Drug Class
- 3.6.2. Market attractiveness analysis, by Route of Administration
- 3.6.3. Market attractiveness analysis, by Distribution Channel
- 3.6.4. Market attractiveness analysis, by Region
- Chapter 4. Global Osteoarthritis Drug Market - Competitive Landscape
- 4.1. Company Market Share Analysis
- 4.1.1. Global Osteoarthritis Drug Market: company market share, 2018
- 4.2. Strategic Development
- 4.2.1. Acquisitions & Mergers
- 4.2.2. New Drug Class Launch
- 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
- 4.2.4. Research and Development and Regional Expansion
- 4.1. Company Market Share Analysis
- Chapter 5. Global Osteoarthritis Drug Market - Drug Class Analysis
- 5.1. Global Osteoarthritis Drug Market: Drug Class overview
- 5.1.1. Global Osteoarthritis Drug Market revenue share, by Drug Class, 2016 and 2025(USD Million)
- 5.2. Corticosteroids
- 5.2.1. Global corticosteroids market, 2016 - 2025(USD Million)
- 5.3. NSAIDs
- 5.3.1. Global NSAIDs market, 2016 - 2025(USD Million)
- 5.4. Viscosupplementation agents
- 5.4.1. Global Viscosupplementation agents market, 2016 - 2025(USD Million)
- 5.5. Others
- 5.5.1. Global Others market, 2016 - 2025(USD Million)
- 5.1. Global Osteoarthritis Drug Market: Drug Class overview
- Chapter 6. Global Osteoarthritis Drug Market - Route of Administration Analysis
- 6.1. Global Osteoarthritis Drug Market: Route of Administration overview
- 6.1.1. Global Osteoarthritis Drug Market revenue share, by Route of Administration, 2016 and 2025(USD Million)
- 6.2. Oral
- 6.2.1. The global Oral market, 2016 - 2025(USD Million)
- 6.3. Parenteral
- 6.3.1. Global Parenteral market, 2016 - 2025(USD Million)
- 6.4. Topical
- 6.4.1. Global Topical market, 2016 - 2025(USD Million)
- 6.1. Global Osteoarthritis Drug Market: Route of Administration overview
- Chapter 7. Global Osteoarthritis Drug Market - Distribution Channel Analysis
- 7.1. Global Osteoarthritis Drug Market: Distribution Channel overview
- 7.1.1. Global Osteoarthritis Drug Market revenue share, by Distribution Channel, 2016 and 2025(USD Million)
- 7.2. Hospital Pharmacies
- 7.2.1. Global Osteoarthritis Drug Market for Hospital Pharmacies, 2016 - 2025(USD Million)
- 7.3. Retail Pharmacies
- 7.3.1. Global Osteoarthritis Drug Market for Retail pharmacies, 2016 - 2025(USD Million)
- 7.4. Online Pharmacies
- 7.4.1. Global Osteoarthritis Drug Market for online pharmacies, 2016 - 2025(USD Million)
- 7.1. Global Osteoarthritis Drug Market: Distribution Channel overview
- Chapter 8. Global Osteoarthritis Drug Market - Regional Analysis
- 8.1. Global Osteoarthritis Drug Market: Regional overview
- 8.1.1. Global Osteoarthritis Drug Market revenue share, by Region, 2016 and 2025
- 8.2. North America
- 8.2.1. North America Osteoarthritis Drug Market revenue, by Drug Class, 2016 - 2025(USD Million)
- 8.2.2. North America Osteoarthritis Drug Market revenue, by Route of Administration, 2016 - 2025(USD Million)
- 8.2.3. North America Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 - 2025(USD Million)
- 8.2.4. The U.S.
- 8.2.4.1. The U.S. Osteoarthritis Drug Market revenue, by Drug Class, 2016 - 2025(USD Million)
- 8.2.4.2. The U.S. Osteoarthritis Drug Market revenue, by Route of Administration, 2016 - 2025(USD Million)
- 8.2.4.3. The U.S. Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 - 2025(USD Million)
- 8.2.5. Rest of North America
- 8.2.5.1. Rest of North America Osteoarthritis Drug Market revenue, by Drug Class, 2016 - 2025(USD Million)
- 8.2.5.2. Rest of North America Osteoarthritis Drug Market revenue, by Route of Administration, 2016 - 2025(USD Million)
- 8.2.5.3. Rest of North America Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 - 2025(USD Million)
- 8.3. Europe
- 8.3.1. Europe Osteoarthritis Drug Market revenue, by Drug Class, 2016 - 2025(USD Million)
- 8.3.2. Europe Osteoarthritis Drug Market revenue, by Route of Administration, 2016 - 2025(USD Million)
- 8.3.3. Europe Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 - 2025(USD Million)
- 8.3.4. Germany
- 8.3.4.1. Germany Osteoarthritis Drug Market revenue, by Drug Class, 2016 - 2025(USD Million)
- 8.3.4.2. Germany Osteoarthritis Drug Market revenue, by Route of Administration, 2016 - 2025(USD Million)
- 8.3.4.3. Germany Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 - 2025(USD Million)
- 8.3.5. UK
- 8.3.5.1. UK Osteoarthritis Drug Market revenue, by Drug Class, 2016 - 2025(USD Million)
- 8.3.5.2. UK Osteoarthritis Drug Market revenue, by Route of Administration, 2016 - 2025(USD Million)
- 8.3.5.3. UK Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 - 2025(USD Million)
- 8.3.6. France
- 8.3.6.1. France Osteoarthritis Drug Market revenue, by Drug Class, 2016 - 2025(USD Million)
- 8.3.6.2. France Osteoarthritis Drug Market revenue, by Route of Administration, 2016 - 2025(USD Million)
- 8.3.6.3. France Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 - 2025(USD Million)
- 8.3.7. Rest of Europe
- 8.3.7.1. Rest of Europe Osteoarthritis Drug Market revenue, by Drug Class, 2016 - 2025(USD Million)
- 8.3.7.2. Rest of Europe Osteoarthritis Drug Market revenue, by Route of Administration, 2016 - 2025(USD Million)
- 8.3.7.3. Rest of Europe Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 - 2025(USD Million)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific Osteoarthritis Drug Market revenue, by Drug Class, 2016 - 2025(USD Million)
- 8.4.2. Asia Pacific Osteoarthritis Drug Market revenue, by Route of Administration, 2016 - 2025(USD Million)
- 8.4.3. Asia Pacific Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 - 2025(USD Million)
- 8.4.4. China
- 8.4.4.1. China Osteoarthritis Drug Market revenue, by Drug Class, 2016 - 2025(USD Million)
- 8.4.4.2. China Osteoarthritis Drug Market revenue, by Route of Administration, 2016 - 2025(USD Million)
- 8.4.4.3. China Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 - 2025(USD Million)
- 8.4.5. Japan
- 8.4.5.1. Japan Osteoarthritis Drug Market revenue, by Drug Class, 2016 - 2025(USD Million)
- 8.4.5.2. Japan Osteoarthritis Drug Market revenue, by Route of Administration, 2016 - 2025(USD Million)
- 8.4.5.3. Japan Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 - 2025(USD Million)
- 8.4.6. India
- 8.4.6.1. India Osteoarthritis Drug Market revenue, by Drug Class, 2016 - 2025(USD Million)
- 8.4.6.2. India Osteoarthritis Drug Market revenue, by Route of Administration, 2016 - 2025(USD Million)
- 8.4.6.3. India Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 - 2025(USD Million)
- 8.4.7. Rest of Asia Pacific
- 8.4.7.1. Rest of Asia Pacific Osteoarthritis Drug Market revenue, by Drug Class, 2016 - 2025(USD Million)
- 8.4.7.2. Rest of Asia Pacific Osteoarthritis Drug Market revenue, by Route of Administration, 2016 - 2025(USD Million)
- 8.4.7.3. Rest of Asia Pacific Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 - 2025(USD Million)
- 8.5. Latin America
- 8.5.1. Latin America Osteoarthritis Drug Market revenue, by Drug Class, 2016 - 2025(USD Million)
- 8.5.2. Latin America Osteoarthritis Drug Market revenue, by Route of Administration, 2016 - 2025(USD Million)
- 8.5.3. Latin America Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 - 2025(USD Million)
- 8.5.4. Brazil
- 8.5.4.1. Brazil Osteoarthritis Drug Market revenue, by Drug Class, 2016 - 2025(USD Million)
- 8.5.4.2. Brazil Osteoarthritis Drug Market revenue, by Route of Administration, 2016 - 2025(USD Million)
- 8.5.4.3. Brazil Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 - 2025(USD Million)
- 8.5.5. Rest of Latin America
- 8.5.5.1. Rest of Latin America Osteoarthritis Drug Market revenue, by Drug Class, 2016 - 2025(USD Million)
- 8.5.5.2. Rest of Latin America Osteoarthritis Drug Market revenue, by Route of Administration, 2016 - 2025(USD Million)
- 8.5.5.3. Rest of Latin America Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 - 2025(USD Million)
- 8.6. The Middle East and Africa
- 8.6.1. The Middle East and Africa Osteoarthritis Drug Market revenue, by Drug Class, 2016 - 2025(USD Million)
- 8.6.2. The Middle East and Africa Osteoarthritis Drug Market revenue, by Route of Administration, 2016 - 2025(USD Million)
- 8.6.3. The Middle East and Africa Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 - 2025(USD Million)
- 8.1. Global Osteoarthritis Drug Market: Regional overview
- Chapter 9. Company Profile
- 9.1. Pfizer Inc.
- 9.1.1. Overview
- 9.1.2. Financials
- 9.1.3. Route of Administration portfolio
- 9.1.4. Business strategy
- 9.1.5. Recent developments
- 9.2. Horizon Pharma plc
- 9.2.1. Overview
- 9.2.2. Financials
- 9.2.3. Route of Administration portfolio
- 9.2.4. Business strategy
- 9.2.5. Recent developments
- 9.3. Ferring B.V.
- 9.3.1. Overview
- 9.3.2. Financials
- 9.3.3. Route of Administration portfolio
- 9.3.4. Business strategy
- 9.3.5. Recent developments
- 9.4. Bioventus, Inc.
- 9.4.1. Overview
- 9.4.2. Financials
- 9.4.3. Route of Administration portfolio
- 9.4.4. Business strategy
- 9.4.5. Recent developments
- 9.5. Sanofi
- 9.5.1. Overview
- 9.5.2. Financials
- 9.5.3. Route of Administration portfolio
- 9.5.4. Business strategy
- 9.5.5. Recent developments
- 9.6. Flexion Therapeutics, Inc.
- 9.6.1. Overview
- 9.6.2. Financials
- 9.6.3. Route of Administration portfolio
- 9.6.4. Business strategy
- 9.6.5. Recent developments
- 9.7. Alkem Laboratories
- 9.7.1. Overview
- 9.7.2. Financials
- 9.7.3. Route of Administration portfolio
- 9.7.4. Business strategy
- 9.7.5. Recent developments
- 9.8. Anika Therapeutics, Inc.
- 9.8.1. Overview
- 9.8.2. Financials
- 9.8.3. Route of Administration portfolio
- 9.8.4. Business strategy
- 9.8.5. Recent developments
- 9.9. Chugai Pharmaceutical Co., Limited
- 9.9.1. Overview
- 9.9.2. Financials
- 9.9.3. Route of Administration portfolio
- 9.9.4. Business strategy
- 9.9.5. Recent developments
- 9.10. Zimmer Biomet Holdings, Inc.
- 9.10.1. Overview
- 9.10.2. Financials
- 9.10.3. Route of Administration portfolio
- 9.10.4. Business strategy
- 9.10.5. Recent developments
- 9.1. Pfizer Inc.
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global Osteoarthritis Drug Market revenue, 2016 – 2025 (USD Million)
4. Porter’s five forces analysis
5. Osteoarthritis Drug Market attractiveness analysis, by Drug Class
6. Osteoarthritis Drug Market attractiveness analysis, by Route of Administration
7. Osteoarthritis Drug Market attractiveness analysis, by Distribution Channel
8. Osteoarthritis Drug Market: Market attractiveness analysis, by region
9. Company market share analysis, 2018
10. Global Osteoarthritis Drug Market revenue share by Drug Class, 2016 and 2025
11. Global Osteoarthritis Drug Market, 2016 – 2025 (USD Million)
a. Global Corticosteroids market, 2016 – 2025(USD Million)
b. Global NSAIDs market, 2016 – 2025(USD Million)
c. Global viscosupplementation agents market, 2016 – 2025(USD Million)
d. Global others market, 2016 – 2025(USD Million)
12. Global Osteoarthritis Drug Market revenue share by Route of Administration, 2016 and 2025
13. Global Osteoarthritis Drug Market, 2016 – 2025 (USD Million)
a. Global Oral market, 2016 – 2025(USD Million)
b. Global Parenteral market, 2016 – 2025(USD Million)
c. Global Topical Market, 2016-2025(USD Million)
14. Global Osteoarthritis Drug Market revenue share by Distribution Channel, 2016 and 2025
15. Global Osteoarthritis Drug Market, 2016 – 2025 (USD Million)
a. Hospital Pharmacies, 2016 – 2025(USD Million)
b. Retail pharmacies, 2016 – 2025(USD Million)
c. Online Pharmacies, 2016 – 2025(USD Million)
Table Of Tables
List of Tables
1. Osteoarthritis Drug Market: Market Snapshot
2. Drivers of global Osteoarthritis Drug Market: Impact analysis
3. Restraints of Osteoarthritis Drug Market: Impact analysis
4. North America Osteoarthritis Drug Market revenue, by Drug Class, 2016 – 2025(USD Million)
5. North America Osteoarthritis Drug Market revenue, by Route of Administration, 2016 – 2025 (USD Million)
6. North America Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 – 2025(USD Million)
7. The U.S. Osteoarthritis Drug Market revenue, by Drug Class, 2016 – 2025(USD Million)
8. The U.S. Osteoarthritis Drug Market revenue, by Route of Administration, 2016 – 2025(USD Million)
9. The U.S. Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 – 2025(USD Million)
10. Rest of North America Osteoarthritis Drug Market revenue, by Drug Class, 2016 – 2025(USD Million)
11. Rest of North America Osteoarthritis Drug Market revenue, by Route of Administration, 2016 – 2025(USD Million)
12. Rest of North America Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 – 2025(USD Million)
13. Rest of North America Osteoarthritis Drug Market revenue, by Region, 2016 – 2025(USD Million)
14. Europe Osteoarthritis Drug Market revenue, by Drug Class, 2016 – 2025(USD Million)
15. Europe Osteoarthritis Drug Market revenue, by Route of Administration, 2016 – 2025(USD Million)
16. Europe Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 – 2025(USD Million)
17. Germany Osteoarthritis Drug Market revenue, by Drug Class, 2016 – 2025(USD Million)
18. Germany Osteoarthritis Drug Market revenue, by Route of Administration, 2016 – 2025(USD Million)
19. Germany Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 – 2025(USD Million)
20. UK Osteoarthritis Drug Market revenue, by Drug Class, 2016 – 2025(USD Million)
21. UK Osteoarthritis Drug Market revenue, by Route of Administration, 2016 – 2025(USD Million)
22. UK Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 – 2025(USD Million)
23. France Osteoarthritis Drug Market revenue, by Drug Class, 2016 – 2025(USD Million)
24. France Osteoarthritis Drug Market revenue, by Route of Administration, 2016 – 2025(USD Million)
25. France Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 – 2025(USD Million)
26. Rest of Europe Osteoarthritis Drug Market revenue, by Drug Class, 2016 – 2025(USD Million)
27. Rest of Europe Osteoarthritis Drug Market revenue, by Route of Administration, 2016 – 2025(USD Million)
28. Rest of Europe Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 – 2025(USD Million)
29. Asia Pacific Osteoarthritis Drug Market revenue, by Drug Class, 2016 – 2025(USD Million)
30. Asia Pacific Osteoarthritis Drug Market revenue, by Route of Administration, 2016 – 2025(USD Million)
31. Asia Pacific Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 – 2025(USD Million)
32. China Osteoarthritis Drug Market revenue, by Drug Class, 2016 – 2025(USD Million)
33. China Osteoarthritis Drug Market revenue, by Route of Administration, 2016 – 2025(USD Million)
34. China Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 – 2025(USD Million)
35. Japan Osteoarthritis Drug Market revenue, by Drug Class, 2016 – 2025(USD Million)
36. Japan Osteoarthritis Drug Market revenue, by Route of Administration, 2016 – 2025(USD Million)
37. Japan Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 – 2025(USD Million)
38. India Osteoarthritis Drug Market revenue, by Drug Class, 2016 – 2025(USD Million)
39. India Osteoarthritis Drug Market revenue, by Route of Administration, 2016 – 2025(USD Million)
40. India Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 – 2025(USD Million)
41. Rest of Asia Pacific Osteoarthritis Drug Market revenue, by Drug Class, 2016 – 2025(USD Million)
42. Rest of Asia Pacific Osteoarthritis Drug Market revenue, by Route of Administration, 2016 – 2025(USD Million)
43. Rest of Asia Pacific Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 – 2025(USD Million)
44. Latin America Osteoarthritis Drug Market revenue, by Drug Class, 2016 – 2025(USD Million)
45. Latin America Osteoarthritis Drug Market revenue, by Route of Administration, 2016 – 2025(USD Million)
46. Latin America Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 – 2025(USD Million)
47. Brazil Osteoarthritis Drug Market revenue, by Drug Class, 2016 – 2025(USD Million)
48. Brazil Osteoarthritis Drug Market revenue, by Route of Administration, 2016 – 2025(USD Million)
49. Brazil Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 – 2025(USD Million)
50. Rest of Latin America Osteoarthritis Drug Market revenue, by Drug Class, 2016 – 2025(USD Million)
51. Rest of Latin America Osteoarthritis Drug Market revenue, by Route of Administration, 2016 – 2025(USD Million)
52. Rest of Latin America Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 – 2025(USD Million)
53. The Middle East and Africa Osteoarthritis Drug Market revenue, by Drug Class, 2016 – 2025(USD Million)
54. The Middle East and Africa Osteoarthritis Drug Market revenue, by Route of Administration, 2016 – 2025(USD Million)
55. The Middle East and Africa Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 – 2025(USD Million)
Methodology
FrequentlyAsked Questions
Osteoarthritis is a joint degenerative disorder that affects various joint, which mostly affects the elderly population. In osteoarthritis, the smooth gliding surface between joints that provides easy movement is affected with age.
According to study, the Osteoarthritis Drug Market size was worth around USD 9.35 billion in 2023 and is predicted to grow to around USD 16.91 billion by 2032.
The CAGR value of Osteoarthritis Drug Market is expected to be around 6.8% during 2024-2032.
North America has been leading the Osteoarthritis Drug Market and is anticipated to continue on the dominant position in the years to come.
The Osteoarthritis Drug Market is led by players like Pfizer Inc., Horizon Pharma plc, Ferring B.V., Bioventus Inc., Sanofi, Flexion Therapeutics Inc., Alkem Laboratories, Anika Therapeutics Inc., Chugai Pharmaceutical Co., Limited, and Zimmer Biomet Holdings Inc., among others.
HappyClients
